Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Eledon Pharmaceuticals Inc. ELDN

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's lead compound in development is AT-1501 which is the next generation anti-CD40L antibody.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:ELDN)

Fundamentals Snapshot (NDAQ:ELDN)

Opinion & Analysis (NDAQ:ELDN)

No current opinion is available.

Bullboard Posts (NDAQ:ELDN)

ELDN - Thursday Rundown, Friday Expectations

<< View Post To Watch Video >>
HDavis - November 11, 2021

Is a Cure for Diabetes Being Studied

Is a Cure for Diabetes Enetering Phase II Trials? https://www.channelchek.com/news-channel/Is_a_Cure_for_Diabetes_Being_Studied_
SmallCapPaul - December 11, 2020

Functional Cure for T1D Discussion

Noble Capital Markets, Inc. Announces Type-1 Diabetes Day- The Beginning of the End; Close to a Cure?   A Panel of World...
SmallCapPaul - November 23, 2020

Novus Acquires Anelixis Therapeutics

Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular...
schoolofrock - September 15, 2020

Nice Move Today

This should be a good one. Phase 1 but very promising imho.
dmacd - January 22, 2019